NYSE:KVUE - New York Stock Exchange, Inc. - US49177J1025 - Common Stock
These companies lead their respective markets, making them must-haves for buy-and-hold dividend investors.
Activist investor Starboard Value LP has reportedly acquired a 7.7% stake worth approximately $500 million in Qorvo Inc. on Thursday, targeting the struggling semiconductor manufacturer for potential operational changes.
These three dividend-paying companies have all raised their payouts every year for at least 40 consecutive years.
The activist investor says Pfizer has underperformed its peers and the broader market since 2019.
Pfizer spinoff Kenvue led the S&P 500 on Monday. Nvidia was close behind.
Elf Beauty appeared to rally along with KVUE on Monday.
(Bloomberg) -- Shares of consumer-products company Kenvue Inc. rose the most in two months after activist investor Starboard Value took a stake in the Tylenol maker with an eye toward making changes to boost the company’s stock price.Most Read from BloombergA Broken Oil Pipeline Plunges South Sudan’s Capital Into ChaosDrug Decriminalization Spawns a Political Debacle for ProgressivesClimate Change Is Killing Buildings in Slow MotionCities Look to AI to Flag Residents’ Trash and Recycling Mistake